|
Age**
|
30 [24–38.50]
|
29 [24–39]
| |
0.646
|
|
Sex
|
|
Male
|
144 (80.0)
|
81/144 (56.3)
| | |
|
Female
|
36 (20.0)
|
24/36 (66.7)
|
0.84 [0.64–1.11]
|
0.257
|
|
Sexual orientation
|
|
Homosexual
|
63 (35.0)
|
35/63 (55.6)
| |
0.853
|
|
Heterosexual
|
89 (49.4)
|
53/89 (59.6)
|
1.07 [0.81–1.42]
| |
|
Bisexual
|
28 (15.6)
|
17/28 (60.7)
|
1.09 [0.75–1.58]
| |
|
Marital status
|
|
Single
|
122 (67.8)
|
68/122 (55.7)
| |
0.778
|
|
Living with someone/partner
|
35 (19.4)
|
22/35 (62.9)
|
1.13 [0.84–1.52]
| |
|
Married
|
12 (6.7)
|
8/12 (66.7)
|
1.20 [0.78–1.84]
| |
|
Divorced/widowed
|
11 (6.1)
|
7/11 (63.6)
|
1.14 [0.71–1.83]
| |
|
Number of children
|
|
0
|
115 (63.9)
|
60/115 (52.2)
| |
0.029*
|
|
1
|
21 (11.7)
|
13/21 (61.9)
|
1.19 [0.81–1.73]
| |
|
2
|
25 (13.9)
|
19/25 (76)
|
1.46 [1.10–1.93]
| |
|
≥ 3
|
19 (10.6)
|
13/19 (68.4)
|
1.31 [0.92–1.86]
| |
|
Monthly family incomes**
|
1000 [625–1500]
|
1000 [700–1800]
| |
0.302
|
|
ART prescription
|
|
ZDV + 3TC + EFV
|
62 (34.4)
|
39/62 (62.9)
| |
0.861
|
|
TDF + 3TC + EFV
|
47 (26.1)
|
25/47 (53.2)
|
0.85 [0.61–1.18]
| |
|
ABC + 3TC + EFV
|
26 (14.4)
|
14/26 (53.8)
|
0.86 [0.57–1.28]
| |
|
TDF + 3TC + ATV + RTV
|
15 (8.3)
|
9/15 (60)
|
0.95 [0.61–1.50]
| |
|
Other
|
30 (16.7)
|
18/30 (60)
|
0.95 [0.67–1.35]
| |
|
Place of diagnosis
|
|
Hospital
|
95 (52.8)
|
60/95 (63.2)
| |
0.035*
|
|
Primary Health Center
|
59 (32.8)
|
32/59 (54.2)
|
0.86 [0.65–1.14]
| |
|
Private lab or clinic
|
16 (8.9)
|
5/16 (31.3)
|
0.49 [0.24–1.04]
| |
|
Ambulatory care
|
10 (5.6)
|
8/10 (80)
|
1.27 [0.90–1.79]
| |
|
Viral Load
| | | |
0.513
|
|
> 40
|
81 (45.0)
|
51/81 (63)
| |
0.255
|
|
≤ 40
|
99 (55.0)
|
54/99 (54.5)
|
1.15 [0.90–1.48]
| |
|
Nivel de CD4**
|
356 [261–527]
|
362 [264–516]
| |
0.879
|
|
≤ 300
|
66 (36.7)
|
37/66 (56.1)
| |
0.638
|
|
> 300
|
114 (63.3)
|
68/114 (59.6)
|
0.94 [0.72–1.22]
| |
|
Years with no ART since diagnosis**
|
2 [1–5]
|
2 [1–5]
| |
0.662
|
|
≥ 1
|
45 (25)
|
26/45 (57.8)
| |
0.930
|
|
< 1
|
135 (75)
|
79/135 (58.5)
|
0.99 [0.74–1.32]
| |
|
Years living with HIV**
|
2 [1–3]
|
2 [1–3]
| |
0.980
|
|
≥ 1
|
141 (78.3)
|
86/141 (61)
| |
0.169
|
|
< 1
|
39 (21.7)
|
19/39 (48.7)
|
1.25 [0.88–1.77]
| |
|
Years taking ART**
|
1 [1, 2]
|
1 [1, 2]
| |
0.988
|
|
≥ 1
|
122 (67.8)
|
73/122 (59.8)
| |
0.553
|
|
< 1
|
58 (32.2)
|
32/58 (55.2)
|
1.08 [0.82–1.43]
| |
|
Opportunistic infection
|
|
Yes
|
80 (44.4)
|
43/80 (53.8)
| |
0.265
|
|
No
|
100 (55.6)
|
62/100 (62)
|
0.87 [0.67–1.12]
|
|
Pulmonary tuberculosis
|
|
Yes
|
18 (10.0)
|
6/18 (33.3)
| |
0.023*
|
|
No
|
162 (90.0)
|
99/162 (61.1)
|
0.55 [0.28–1.06]
|
|
Side effects with actual ART prescription
| |
|
Yes
|
92 (51.1)
|
62/92 (67.4)
| |
0.012*
|
|
No
|
88 (48.9)
|
43/88 (48.9)
|
1.38 [1.07–1.78]
|
|
Action taken with side effects
| |
|
Ask for medical advice
|
57 (62.0)
|
38/57 (66.7)
| |
0.031*
|
|
Wait it to stop
|
28 (30.4)
|
22/28 (78.6)
|
1.18 [0.90–1.54]
|
|
Keep taking my ART
|
4 (4.3)
|
2/4 (50)
|
0.75 [0.28–2.03]
|
|
Did not answer
|
3 (3.3)
|
0/3 (0)
|
–
|
|
ART abandoned at anytime
|
|
Yes
|
83 (46.1)
|
72/83 (86.7)
| |
0.001*
|
|
No
|
97 (53.9)
|
33/97 (34)
|
2.55 [1.91–3.41]
|
|
Length of ART abandon
|
|
> 30 days
|
15 (18.1)
|
9/15 (60)
| |
0.001*
|
|
10–30 days
|
16 (19.3)
|
14/16 (87.5)
|
1.46 [0.93–2.29]
|
|
1–9 days
|
52 (62.7)
|
49/52 (94.2)
|
1.57 [1.03–2.39]
|
|
Reason for abandonment
|
|
Forgetfulness or neglect when attending a commitment, meeting or work
|
35 (40.7)
|
35/35 (100)
| |
0.033*
|
|
Bureaucracy to get access to ART
|
17 (19.8)
|
13/17 (76.5)
|
0.76 [0.59–1.00]
|
|
Lack of privacy or feeling better
|
11 (12.8)
|
9/11 (81.8)
|
0.82 [0.62–1.08]
|
|
Fear of side effects
|
8 (9.3)
|
6/8 (75)
|
0.75 [0.50–1.12]
|
|
Others
|
15 (17.4)
|
11/15 (73.3)
|
0.73 [0.54–1.00]
|
